How to build a stock portfolio that provides a steady stream of income for years. Our 10 picks.
Something unusual is happening at the U.S. Food and Drug Administration, and it’s giving investors the jitters.
A shift toward mid-caps and more healthcare and internet stocks is weighing on the fund now—but could mean less volatility later.
Strategist Marko Papic sees stocks gaining more ground, but says investors need to prepare for a new geopolitical world order.
Am I getting desperate, or do European stocks look attractive? Let’s not rule out a combination of the two.